Casirivimab-Imdevimab treatment is associated with reduced rates of hospitalization among high-risk patients with mild to moderate coronavirus disease-19.
EClinicalMedicine
; 40: 101102, 2021 Oct.
Article
en En
| MEDLINE
| ID: mdl-34485873
Texto completo:
1
Base de datos:
MEDLINE
Tipo de estudio:
Etiology_studies
/
Risk_factors_studies
Idioma:
En
Revista:
EClinicalMedicine
Año:
2021
Tipo del documento:
Article